Clinical Characteristics and Treatment of Patients Infected with COVID-19 in Shishou, China
27 Pages Posted: 20 Feb 2020
Xiongwei Qin
The People's Hospital of Shishou
Shaohong Qiu
The People's Hospital of Shishou
Abstract
Background: (NCP) Novel coronavirus pneumonia that recently occurred in Hubei Province, China is caused by a new type of coronavirus (new coronavirus in 2019) (COVID-19)1-4 . Our research object is patients living in Shishou, Hubei Province, Shishou is a city about 300 kilometers away from Wuhan. The characteristics of patients in this city are different from those in Wuhan. We report the epidemiological and clinical characteristics of patients in this city, laboratory and radiological characteristics, as well as treatment and clinical outcomes. We also focus on how we treat the disease, how to treat it with antibiotics, hormones etc. to achieve a higher cure rate. In particular, we introduced the role of methylprednisolone in the treatment of ICU patients. The methylprednisolone protocol was developed by Wuhan Union Hospital and certified by the Chinese Ministry of Health.